Counterforce Health Team

Counterforce Health Team

How to Get Poteligeo (mogamulizumab-kpkc) Approved by Aetna CVS Health in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Poteligeo Covered in Washington Poteligeo (mogamulizumab-kpkc) requires prior authorization from Aetna CVS Health for relapsed/refractory mycosis fungoides or Sézary syndrome after ≥1 prior systemic therapy. Your oncologist submits documentation via the Aetna provider portal showing confirmed CTCL diagnosis, prior treatment failures, and medical necessity. If denied,
7 min read

The Requirements Checklist to Get Revlimid (lenalidomide) Covered by UnitedHealthcare in North Carolina

Answer Box: Getting Revlimid Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Revlimid (lenalidomide) in North Carolina, with specific criteria for multiple myeloma, MDS, and mantle cell lymphoma. The fastest path: verify REMS enrollment, submit PA via UHC provider portal with diagnosis-specific documentation, and use North Carolina&
5 min read

How to Get Ocrevus (Ocrelizumab) Covered by UnitedHealthcare in California: Renewal Guide, Appeal Scripts, and Timeline

Answer Box: Getting Ocrevus Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Ocrevus (ocrelizumab) with annual renewal documentation showing clinical response. Submit via the UHC Provider Portal with MS diagnosis confirmation, prior DMT trials, and evidence of treatment benefit (stable/improved disability scores, reduced relapses, or MRI stability)
6 min read

How to Get Pombiliti (cipaglucosidase alfa-atga) Covered by UnitedHealthcare in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: To get Pombiliti (cipaglucosidase alfa-atga) covered by UnitedHealthcare in Florida, you'll need prior authorization with documented failure on current ERT (step therapy). Submit via UHCprovider.com or OptumRx forms (fax 844-403-1027). Include late-onset Pompe diagnosis, enzyme/genetic testing, and prior therapy outcomes. If denied, appeal within
5 min read

How to Get Zolgensma (onasemnogene abeparvovec) Covered by UnitedHealthcare in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Zolgensma Covered by UnitedHealthcare in Michigan Fastest Path to Approval: UnitedHealthcare requires prior authorization for Zolgensma through their medical benefit policy. You need genetic testing confirming bi-allelic SMN1 mutations, age under 24 months at infusion, anti-AAV9 antibody titer ≤1:50, and treatment at a certified center. If
6 min read

How to Get Zolgensma (onasemnogene abeparvovec-xioi) Covered by Humana in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Zolgensma Covered by Humana in New Jersey Zolgensma (onasemnogene abeparvovec-xioi) requires prior authorization from Humana Medicare Advantage plans in New Jersey as a high-cost specialty gene therapy (HCPCS J3399). Coverage requires genetic confirmation of SMA with SMN1 mutation, age under 2 years, negative AAV9 antibody titers, and
6 min read